From the Strategy and Health areas of SILO we are accompanying the authorities responsible for the PERTE for Vanguard Health in its mid-term evaluation, which will be presented soon. This process seeks to value the impact of PERTE in the ecosystem of R&D&I in health in our country.<\/p>\n
As part of this accompaniment, we have conducted interviews with key players in the ecosystem and dynamized the session “The future of R&D&I in health as a lever for health, economic and industrial transformation in Spain”.<\/i> In this process, shared with the working group – made up of representatives of the General State Administration, autonomous communities, business associations, patients’ associations and third-sector entities – the main challenges and opportunities of the healthcare R&D&I system were identified.<\/p>\n
During the session, the strategic objectives, cross-cutting lines of action and priority areas of investment that will guide the next steps of PERTE for Vanguard Health were also presented.<\/p>\n","protected":false},"excerpt":{"rendered":"
From the Strategy and Health areas of SILO we are accompanying the authorities responsible for the PERTE for Vanguard Health in its mid-term evaluation, which will be presented soon. This process seeks to value the impact of PERTE in the ecosystem of R&D&I in health in our country. As part of this accompaniment, we have […]<\/p>\n","protected":false},"author":1,"featured_media":2962,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[49,50],"class_list":["post-3040","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualidad-en","tag-health","tag-perte-en"],"yoast_head":"\n